Newsletters

Hier wäre ein Untertitel gut

25. December 2019

Newsletter: SWISS BRIDGE AWARD 2019

New cellular immunotherapies cannot be compared with classical drugs. Drugs are clearly defined chemical substances, but the new treatments are alive; using cancer patients´ immune systems from their own bodies to fight cancer at the cellular level. Patients´ cells are genetically modified and multiplied in a laboratory – then transferred back into their bodies, where the cells can act with increased strength against degenerated tumour cells, thanks to genetic upgrading.

01. May 2018

Newsletter: SWISS BRIDGE AWARD 2018

Immunotherapies, such as checkpoint inhibitors – whose discoverers won this year`s Nobel Prize for Physiology and Medicine – raise hope and are promising, because they can sometimes also cure patients with advanced-stage cancers. However, immunotherapies are also cause for frustration because they often fail, with only about 20% of the treated patients responding to these types of therapies. Medical science does not yet know in advance with whom these therapies will work.

01. May 2017

Newsletter: SWISS BRIDGE AWARD 2017 - 2

This year‘s Swiss Bridge Award goes to a research group from Israel and a research group from Switzerland. With the 250 000 Swiss Francs awarded to each, the researchers aim to investigate interactions between cancer cells and the somatic cells in their immediate environment.
The 2017 Swiss Bridge Foundation’s Award is being presented to researchers under the age of 45 years old who are pursuing the investigation of the complex interactions with which tumor cells and cells within their immediate environment influence each other.

01. March 2017

Newsletter: SWISS BRIDGE AWARD 2017 - 1

We launched our activities in April at the University of Zurich. “Insight into cancer research" - It was a unique opportunity to look over the shoulders of Prof. Mosimann and his team while they carried out their fascinating research. Prof. Mosimann was awarded the 2016 SWISS BRIDGE AWARD, among the most prestigious international awards for pioneering cancer research projects. His research in the field of rare cancers uses the zebrafish to decipher the disease and identify potential therapeutic approaches.

02. November 2015

Newsletter SWISS BRIDGE AWARD 2015

In the past 14 years CHF 7.850 Mio were paid or committed to 40 cancer research teams from 10 Countries (of approx. 800 projects evaluated).

On 3rd November 2015, two research teams (of 48 projects evaluated) were awarded with CHF 250’000.00 each for their outstanding research projects in the field of cancer stem cells.

Contact

Donor details

Donor‘s account

  • Credit Suisse | 8070 Zurich
  • IBAN:
    CH52 0483 5095 7385 1100 0
  • PC:
    60-559822-6

Social media

Cookies die gesetzt werde um die Website korrekt benutzen zu können.